Neuronetics Inc.的最大独立股东Jorey Chernett近日发声，敦促公司管理层立即启动对战略替代方案的全面评估。这一评估范围广泛，其中明确包括考虑出售其经颅磁刺激（TMS）业务的可能性。此举凸显了主要股东对公司未来发展方向的高度关切，并期望通过战略审视为股东创造更大价值。
Neuronetics Inc.的最大独立股东Jorey Chernett近日发声，敦促公司管理层立即启动对战略替代方案的全面评估。这一评估范围广泛，其中明确包括考虑出售其经颅磁刺激（TMS）业务的可能性。此举凸显了主要股东对公司未来发展方向的高度关切，并期望通过战略审视为股东创造更大价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.